France

Archimedes Pharma France markets specialty products to specialist prescribers in the areas of pain, oncology and Parkinson’s disease. This expertise underpins the commercial potential for the recent launch in France of the transformational product for Archimedes, PecFent^® (fentanyl pectin nasal spray), an innovative nasal spray aimed at managing breakthrough pain in cancer.

Key products marketed in France include:

• Gliadel^® implant (carmustine). View the SmPC
• Apomorphine injection (apomorphine HCl). View the SmPC
• PecFent^® (fentanyl pectin nasal spray). View the SmPC